DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025 ...

Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.

New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adherence, glucometrics and hypoglycemic outcomes Eversense 365 delivered ...

Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...

The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult ...

DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom ...

After introducing the plan internationally in September, Google is bringing its AI Plus subscription to 35 new countries, including the US. Compared to AI Pro’s “higher access” at $19.99 per month (in ...

Researchers have demonstrated that quantum entanglement can link atoms across space to improve measurement accuracy. By splitting an entangled group of atoms into separate clouds, they were able to ...

A reliable leaker has revealed Sony's main PlayStation Plus Monthly offering for February, more than a week before it becomes available. Boxing game Undisputed will headline next month's lineup, ...

Dexcom is already working on its G8 sensor for continuous glucose monitoring (CGM). But before you get too excited, the product is still a couple of years out, CEO Jake Leach told MD+DI during the J.P ...